Summit Therapeutics Inc. · NASDAQ:SMMT

Duggan Robert W exercised options for 500,000 Summit Therapeutics Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 16, 2026

On Nov 16, 2026, Duggan Robert W (Director, Co-Chief Executive Officer, 10% owner) exercised options for 500,000 Summit Therapeutics Inc. shares at US$1.06 for US$530K, leaving 531,000 shares. Filed Nov 16, 2026 (Form 4).

Options exercised
500,000 shares
Price
US$1.06
Value
US$530K
Holding after
531,000 shares (held indirectly)
Trading plan
No
Role
Director, Co-Chief Executive Officer, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockOption exercise500,000US$1.06531,000Indirect

Source

Download original · View original at SEC

Related